Although endothelial cells have been shown to affect mouse pancreatic development, their precise function in human development remains unclear. Using a coculture system containing human embryonic stem cell (hESC)-derived progenitors and endothelial cells, we found that endothelial cells play a stage-dependent role in pancreatic development, in which they maintain pancreatic progenitor (PP) self-renewal and impair further differentiation into hormone-expressing cells. The mechanistic studies suggest that the endothelial cells act through the secretion of EGFL7. Consistently, endothelial overexpression of EGFL7 in vivo using a transgenic mouse model resulted in an increase of PP proliferation rate and a decrease of differentiation toward endocrine cells. These studies not only identified the role of EGFL7 as the molecular handle involved in the crosstalk between endothelium and pancreatic epithelium, but also provide a paradigm for using hESC stepwise differentiation to dissect the stage-dependent roles of signals controlling organogenesis.
INTRODUCTION
During embryonic development, cell fate is determined by both intrinsic programs and external cell niche. The animal studies suggested that endothelial cell niche provides both supportive and inductive roles throughout pancreas development (Eberhard et al., 2010) . Early studies showed that signals from endothelial cells are essential for the induction of pancreatic organogenesis (Lammert et al., 2001) . Endothelial cells specifically promote early dorsal pancreas development by inducing Ptf1a + pancreatic progenitors (PPs) by activating FGF10 signaling (Yoshitomi and Zaret, 2004; Jacquemin et al., 2006) . Interestingly, some groups recently reported that the endothelial cell niche could restrain epithelium branching and endocrine development. One group shows that blood vessel ablation results in increased pancreatic organ size (Sand et al., 2011) . Another group showed that elimination of endothelial cells increases the size of pancreatic buds . Similarly, another group showed that overexpressing vascular endothelial growth factor A increases embryonic endothelial cell populations and perturbs pancreatic endocrine differentiation (Cai et al., 2012) . However, a complete understanding of the role of endothelial cells in human pancreatic development is still missing. Human embryonic stem cells (hESCs) provide an in vitro platform to study human development. To better understand the signaling from the endothelial cell niche in pancreatic differentiation, we have developed a coculture system of endothelial cells with hESC-derived progenitors under serum-free, chemical-defined conditions. By using the coculture system, we found that endothelial cells maintain PP self-renewal and impair further differentiation into hormone-expressing cells by secreting EGFL7.
RESULTS AND DISCUSSION
Endothelial Cells Promote the Proliferation of PDX1 + Cells in the Chemically Defined Environment To systematically probe the role of an endothelial cell niche in human pancreatic development, we set up a coculture system using endothelial cells and hESCs-derived progenitors. The coculture system is established in a chemically defined culture condition to mimic the serum-free environment during embryonic development. The endothelial cells used in this study were AKT-HUVECs (AKT-activated human umbilical vein endothelial cells) (Kobayashi et al., 2010) or MPECs (mouse pancreas islet endothelial cells). BJ cells, which are human skin fibroblasts, were used as a control for cell-type specificity. To explore the stage-dependent effect of endothelial cells, HUES8 cells were differentiated into three different stages: definitive endoderm (DE), foregut endoderm (FE), or PP populations using a previously established strategy ). The hESCderived populations were cultured together with MPECs or AKT-HUVECs at different ratios and examined for their capacities to self-renew or differentiate ( Figure 1A ). The self-renewal ability was determined by immunostaining with antibodies against a proliferation marker (Ki67) and stage-dependent self-renewal markers, including SOX17 for DE, HNF4a for FE, and PDX1 for PPs. The differentiation ability was determined by immunostaining with antibodies against differentiation markers, including HNF4a for DE, PDX1 for FE, and insulin/glucagon/somatostatin for PPs.
In the coculture condition of MPECs or AKT-HUVECs with the hESCs-derived DE population, neither the number of SOX17 + /Ki67 + cells nor the number of HNF4a + cells changed significantly ( Figure S1A available online), suggesting that endothelial cells do not affect either selfrenewal or differentiation of DE. In the coculture condition with the hESC-derived FE population, the number of PDX1 + cells was significantly increased in the presence of MPECs and AKT-HUVECs, but not BJ cells ( Figure 1B ). In addition, when the hESCs-derived PP population was cultured with MPECs and AKT-HUVECs, the number of PDX1 + cells was significantly elevated as compared with BJ cells ( Figure 1C than control conditions ( Figure 1C ). To further validate that endothelial cells promote PP proliferation, we generated a transgenic Pdx1-EGFP HUES8 cell line, which contains the mouse Pdx1 promoter driving expression of EGFP. The Pdx1-EGFP HUES8 cell line was validated by flow cytometry. After 14 days of differentiation, about 45% of cells were EGFP + , most of which were positively stained by PDX1 antibody ( Figure S1B ). Pdx1-EGFP + cells
were sorted and cocultured with MPECs, AKT-HUVECs, or BJ cells ( Figure S1C ). Figure S2C ) in sorted Pdx1-EGFP + cells was elevated in MPEC coculture condition, but the expression of endocrine progenitor markers (NGN3 and NKX2.2; Figures S2F and S2G) did not significantly differ between BJ and MPEC coculture conditions ( Figure S2F , at day 4, p = 0.1274 for none versus MPECs; p = 0.8968 for BJ versus MPECs). It suggested that PDX1 + cells after coculture with endothelial cells bias to endocrine fate, but have not expressed the endocrine progenitor markers yet. Next, we investigated whether the increased PP population under coculture conditions was due to cell proliferation by measuring the number of PDX1 + /Ki67 cells that are also positive for other PP markers ( Figure 2C ). When cocultured with MPECs and AKT-HUVECs, the number of proliferating PPs increased about 5-fold and 6-to 8-fold, respectively, compared with noncoculture conditions. Sometimes, the number of the proliferating PPs in the presence of BJ cells is lower than noncoculture condition. This might due to the high cell density in coculture condition, which might affect PP proliferation. Figure S2A ). In addition, the global gene expression pattern of PPs expanded in the presence of either AKT-HUVECs or BJ cells showed high similarity (R 2 = 0.9692; Figure 2D , right). The data confirm that PPs maintain cellular identity after expansion by endothelial cells.
Endothelial Cells Maintain Human PP Self-Renewal by Secreting EGFL7
In the coculture system, endothelial cells might function through a secreted factor(s) or by direct cell-cell contact.
To test these possibilities, HUES8 cell-derived PP populations were treated with conditioned medium (Hebrok et al., 2000) collected from MPECs (MPEC-CM) or from AKT-HUVECs (AKT-HUVEC-CM). CM retained similar, but slightly lower, activity compared with intact cells for promoting PP self-renewal ( Figure 3A ). These data suggest that endothelial cells function, at least in part, through a secreted factor(s). We further analyzed the gene expression profiles of AKT-HUVECs, MPECs, and BJ cells to identify candidate secreted factors ( Figures 3B and S3A) . Genes encoding secreted proteins, whose expression in endothelial cells is at least 30-fold higher than in the BJ cells, were selected for further analysis. Among the genes encoding secreted molecules (Table S1) , we tested the abilities of recombinant proteins ANGPT2, EGFL7, CCL13, IL24, PLAU, DHH, and PDGFB to expand human PPs ( Figure 3C ). Only EGFL7 was able to promote PP proliferation ( Figures  3C-3E ). To determine whether EGFL7 was required for the endothelial cell effect, we used shRNA to knockdown EGFL7 expression in AKT-HUVECs. EGFL7 mRNA expression level was decreased by about 63.5% in AKT-HUVECs infected with EGFL7 shRNA lentivirus as compared with a scrambled control lentivirus ( Figure S3B ). When cocultured with EGFL7-shRNA-treated AKT-HUVECs, hESC-derived PPs showed significantly lower proliferation activity as compared with those cocultured with untreated (p = 0.0324) and scrambled-shRNA-treated AKT-HUVECs (p = 0.0387; Figures 3F and 3G ). These results indicate that EGFL7 is both sufficient and necessary for endothelial cells to maintain PP self-renewal. Since EGFL7 has been shown to modulate the NOTCH pathway (Nichol et al., 2010) , we tested whether the NOTCH pathway is involved in endothelial cell-dependent PP expansion. HUES8-derived PP populations were treated with five different NOTCH inhibitors, including DAPT, XX, compound E, III-31-C, and Sulindac sulfide. None of them mimics EGFL7 effect to promote PP proliferation (Figure S3C ). In addition, qRT-PCR analysis showed that EGFL7 treatment did not alter the expression of NOTCH target genes, such as Hes-1 and Hey-1, in Pdx1-GFP + cells ( Figure S3D ). Recent studies suggested that EGFL7 might also activate EGF receptor pathway (Luo et al., 2014; Wu et al., 2009) . Several experiments were performed to determine whether EGF receptor is a downstream signal of EGFL7. Immunocytochemistry suggests that the EGF receptor is expressed in hESC-derived PDX1 + PPs ( Figure S3E ). In addition, microscale thermophoresis binding assay suggested that EGFL7 directly binds to the EGF receptor in vitro (K d = 384 ± 76.5 nM; Figure S3F ). Furthermore, we found that addition of an epidermal growth factor receptor inhibitor (EGFRi) blocks the effect of endothelial cells and EGFL7 to expand PDX1 + PPs ( Figure S3G ). Finally, we found that mRNA expression level for EGF is much lower in AKT-HUVECs (0.09 ± 0.02) and MPECs (0.09 ± 0.02) than BJ fibroblasts (0.6 ± 0.1), as determined by RNaseq (Figure S3H) . Since endothelial cells, but not BJ fibroblasts, promote PPs self-renewal, this suggests that endothelial cells do not promote PP proliferation by secreting EGF. Together, these results indicate that endothelial cells promote PP selfrenewal through the secretion of EGFL7 and through activation of the EGF receptor signaling pathway. To determine whether EGFL7 treatment is capable of promoting PP proliferation in long-term cultures, we tested the expansion and differentiation capacity of PDX1 + PPs to the endocrine lineage following the pulsed expansion with recombinant EGFL7. HUES8-derived PP 
E) Representative images of (D). (F) PDX1
+ /Ki67 + cell number per mm 2 4 days after HUES8-derived PPs were cocultured with AKT-HUVECs carrying shRNA targeting EGFL7 (shRNA-EGFL7) or AKT-HUVECs carrying scrambled control shRNA (scrambled) (n = 3). (G) Representative images of (F). Data were presented as mean ± SD. populations were treated with EGFL7 for different periods of time. One set of samples was fixed and stained with PDX1 and Ki67 antibodies to determine cell proliferation rates. The other set of samples were further differentiated in the absence of EGFL7 for additional 7 days and stained with antibodies against endocrine markers to determine the differentiation potential. The percentage of PDX1 + / Ki67 + cells increased during the first week of EGFL7 treatment ( Figure S3I 
Endothelial Overexpression of Egfl7 In Vivo Increases Proliferation of PPs
To determine the effect of EGFL7 on the PP cell population in vivo, we analyzed pancreatic development in a transgenic mouse model, Tie2:Egfl7. In this strain, the Egfl7 transgene is under the control of the endothelial-specific Tie2 promoter, resulting in a 2-to 3-fold overexpression of EGFL7 (Nichol et al., 2010) . All animal protocols were approved by the Institutional Animal Care and Use Committtee at Weill Cornell Medical College. Whole-mount immunofluorescent staining was performed on E9.5 and E10.5 embryos from C57BL/6 WT mice and Tie2:Egfl7 transgenic mice (TG) (Figures 4A and 4D) . A CD31-positive capillary plexus surrounds the developing pancreatic bud in vivo, demonstrating the proximity of endothelial cells and implicating them as a potential source of EGFL7 to signal to the PDX1 + PP population ( Figure S4A ). Quantification of the vascular coverage at E10.5 demonstrated no significant difference in blood vessel density surrounding the developing pancreatic bud between WT and TG mice (Figure S4B , p = 0.299). At E9.5 and E10.5, the pancreatic buds of TG mice appear larger with less defined edges as compared with WT mice (Figures 4B-4F ). To determine whether the larger pancreatic buds in the TG embryos resulted from increased proliferation of PDX1 + cells, we performed EdU injections of pregnant E10.5 WT and TG mice ( Figures 4G and 4H) . We analyzed the percentage of EdU + PP (PDX1 + ) cells in sections of pancreatic buds ( Figure 4I ). The percentage of proliferating PPs (EdU + /PDX1 + ) in TG mice is significantly higher than WT mice (*p < 0.05; Figure 4I ). In addition, the PDX1 + area in TG mice is significantly increased compared with WT mice (*p = 0.031 in Figure S4C and *p = 0.032 in Figure S4D ). The number of PDX1 + cells in TG mice show the same trend toward increase as the PDX1 + area, although it does not reach significance (p = 0.1144 in Figure S4E , p = 0.065 in Figure S4F ). The increase of the number of PDX1 + cells in TG mice is more pronounced at E15.5
( Figures S4G and S4H , ***p < 0.001). Together, these data suggest that PP proliferation was stimulated by endothelial-specific overexpression of EGFL7 in vivo. In addition, WT E11.5 pancreatic buds were isolated from surrounding mesenchyme and cultured in vitro in the presence or absence of recombinant mouse EGFL7 for 2 days. Figure 4M ). Consistently, the ratio of insulin + area over E-cadherin + area in E15.5 TG pancreatic buds shows a trend toward decrease compared with WT controls ( Figures S4G and S4I , p = 0.396), although it does not reach significance. We also examined the total number of PDX1 + cells and the percentages of Figures S4J and S4K) . Importantly, less than 6% of total PDX1 + cells coexpress NGN3 in both WT and TG pancreatic buds ( Figures S4L and S4M , p = 0.053), suggesting that these PPs have not yet fully committed to endocrine progenitors. Together, these data suggest that EGFL7 suppresses PP differentiation into pancreatic endocrine cells, which is consistent with our results using hESC-derived cells ( Figures S1D and S1E) .
To determine the effect of EGFL7 overexpression in adult beta cell function, we performed a glucose-stimulated insulin secretion (GSIS) test and a glucose tolerance test (GTT) in 8-week-old male TG and WT mice. Strikingly, all four TG mice showed significantly less insulin secretion at both fasting and after glucose stimulation compared with WT controls (fasting, *p = 0.048; after glucose stimulation, *p = 0.027, Figure 4N) . Furthermore, the TG mice showed consistently impaired glucose tolerance ( Figure 4O ). The data suggest that adult TG mice have less functional beta cells than WT control mice.
Stepwise differentiation of hESCs provides a useful platform to study human development. Using a stepwise pancreatic differentiation system, we found that an endothelial cell niche plays a stage-dependent role in human pancreatic development, promoting PP self-renewal and impairing differentiation from PPs toward hormone-expressing cells. Our finding could explain the results from previous animal studies: removing endothelial cells before the PP stage blocks pancreatic development (Lammert et al., 2001) , while forced hypervascularization at the PP stage negatively impacts the later endocrine differentiation (Cai et al., 2012; Magenheim et al., 2011; Sand et al., 2011) . During pancreatic development, the endothelium pattern changes dramatically over time; this might affect the local concentration of paracrine factors, such as EGFL7, which will contribute to the cell fate decision. On the other hand, a recent study proposed that the endothelial cell niche could stimulate PPs to differentiate into insulin-secreting cells (Jaramillo and Banerjee, 2012) . In contrast to our coculture conditions, in which MPECs and AKT-HUVECs survive well after 4 days of coculture ( Figure S4N ), the rat microvascular endothelial cells in that study do not survive well in differentiation conditions and could not be detected after 6 days in culture (Jaramillo and Banerjee, 2012) . Although increased insulin expression was detected in the cocultures, we can speculate that the rat microvascular endothelial cells might provide a transient amplifying signal to expand PPs. If the endothelial cells start to die, the block on differentiation of PPs would be relieved. To test this hypothesis, we cultured hESC-derived PPs in endothelial cell CM for 4 days. The medium was then removed to induce spontaneous differentiation. Consistent with our hypothesis, the hESC-derived cells treated with CM show better differentiation toward insulin-expressing cells ( Figure S4O ).
EGFL7 is a secreted protein that acts as a chemoattractant for endothelial cells, binds to the extracellular matrix, and promotes endothelial cell adhesion (Schmidt et al., 2007) . Here, we identified the role of EGFL7 as the molecular handle involved in the crosstalk between endothelium and pancreatic epithelium, which play as a gatekeeper to maintain PP self-renewal. In this context, it is interesting to note that the developmental stage of pancreatic bud formation (E9.0-E11.5) coincides with the peak in EGFL7 expression in the embryonic vasculature (Fitch et al., 2004) . Our data also suggested that EGFL7 might function through EGF signaling pathway. Consistently, it has been shown that activation of EGF signaling facilitates the PDX1 + cells expansion (Zhang et al., 2009 ). Although our data strongly support our conclusion that EGFL7 promotes PP proliferation, we cannot exclude the possibility that EGFL7 may also promote foregut epithelium differentiation. In addition, recombinant EGFL7 protein was less efficient for expansion of PDX1 + progenitors compared with coculture with endothelial cells. To explain this discrepancy, we considered two possibilities. First, the recombinant EGFL7 protein may lack posttranslational modifications and might not be as functionally active as native EGFL7 secreted by endothelial cells. Second, we cannot exclude the possibility that endothelial cells secrete additional factors that boost the effect of EGFL7. Finally, since Egfl7 transgene is overexpressed in all endothelia, we cannot fully rule out the possibility of systemic effects. The pancreatic development is a highly dynamic process controlling by multiple pathways. Additional work is needed to unravel the dynamic interaction of pancreatic endoderm with endothelial and mesenchymal cell niches. A complete understanding of the underlying mechanism may lead to the development of more efficient strategies to differentiate hESCs/iPSCs into mature glucose-responding cells in vitro.
EXPERIMENTAL PROCEDURES hESC Culture and Differentiation
HUES8 and H1 cells were routinely cultured on irradiated MEF feeders in Dulbecco's modified Eagle's medium (DMEM)/F12 supplemented with 20% KnockOut Serum Replacement, 2 mM Gluta-MAX, 1 mM nonessential amino acids, 1.1 mM b-merceptoethanol, 10 ng/ml basic fibroblast growth factor, and 50 ng/ml normacin. To differentiate to the PP population, hESCs were cultured on feeders to 80%-90% confluency and then treated with a series of chemicals listed in the supplementary method.
Coculture Experiment
MPECs, AKT-HUVECs, and BJ cells were used in the coculture experiments. hESC-derived populations were trypsinized by 0.25% trypsin (Invitrogen), resuspended in DMEM supplemented with 1 3 B27, and plated at a density of 0.8 3 10 3 cells/mm 2 in 96-or 6-well plates. MPECs, AKT-HUVECs, or BJ cells were resuspended in the same medium and plated down in a ratio of 1:1, 1:3, or 1:10 to hESC-derived PPs. One day after plating, medium was changed, and cells were maintained in the incubator for 4 days before fixation or further analysis. Detailed materials and methods are available in the Supplemental Information. 
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